Skip to content

Research on the Optimization of Treatment Schemes and Efficacy Evaluation of Traditional Chinese Medicine Sequential Therapy for the Prevention of Postoperative Intracranial Infection and Pneumonia in Neurosurgery

Research on the Optimization of Treatment Schemes and Efficacy Evaluation of Traditional Chinese Medicine Sequential Therapy for the Prevention of Postoperative Intracranial Infection and Pneumonia in Neurosurgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000658
Enrollment
Unknown
Registered
2025-04-06
Start date
2024-01-25
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial infection after neurosurgery

Interventions

Prevention group of integrated Chinese and Western medicine:Chinese herbal medicine sequential therapy

Sponsors

Bei jing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 69 Years

Inclusion criteria

Inclusion criteria: (1) Admission to ICU immediately after neurosurgery, male or female, age 18 to 69 years old; and (2) Operation time >4 hours; Or postoperative cerebrospinal fluid leakage; Or postoperative placement of surgical area, external ventricular drainage, lumbar puncture drainage and other drainage tubes; Ventriculoperitoneal shunt; Or posterior fossa surgery; Or have a history of diabetes; Or craniocerebral injury and cerebral hemorrhage; Or on the morning of the first day after surgery, the patient had a conscious disorder, or had functional disorders such as expectoration and swallowing, or had artificial airways such as tracheal intubation and tracheotomy; and (3) Assessed patients with severe illness who are expected to remain in the ICU for more than 24 hours.

Exclusion criteria

Exclusion criteria: (1) Preoperative diagnosis of intracranial infection, pneumonia, bloodstream infection and other infections; (2) Have a history of severe allergy to antibiotics and Chinese medicine; (3) Patients with severe chronic organ dysfunction of the heart, lung, liver, kidney, or chronic health status score of 5 on the Acute Physiological and Chronic Health Score (APACHE II); (4) Deep coma, GCS 3 score, pupil dilation no light reaction, no breathing and other near-death symptoms

Design outcomes

Primary

MeasureTime frame
Pulmonary infection score(CPIS);Antibiotic dosage(DDD);APACHE II;Incidence of intracranial infection and pneumonia;

Secondary

MeasureTime frame
Blood routine examination;temperature;hospitalization expenses;Glasgow prognosis score GOS;stool for routine;bacterial culture of CSF;renal function;fatality rate;Hepatic function;

Countries

China

Contacts

Public ContactQiang Wang

Bei jing Tiantan Hospital, Capital Medical University

278206814@qq.com+86 139 1126 1695

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026